The headline: FDA OKs First Human Trials of Embryonic Stem Cells. Note, this treatment will not consist in the direct infusion of human embryonic stem cells, but of neurons derived from ESCs: Starting this summer, the biotech firm Geron will treat a small group of spinal-cord injury patients using neurons derived from stem cells, marking the first time embryonic stem … Continue reading FDA Approves Human Trial of Treatment Derived From ESCs